COVID-19 shot tested to stop type 1 diabetes in kids
NCT ID NCT06452654
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether giving the COVID-19 vaccine (Comirnaty) to children starting at 6 months old can lower their chance of developing type 1 diabetes. The trial will include 2,252 children who have a high genetic risk for the disease. Half will get the vaccine, half a placebo, and researchers will track who develops diabetes-related antibodies or type 1 diabetes over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- COVID-19 vaccine (Comirnaty)
- What this could lead to
- If it works, this could show that COVID-19 vaccination helps prevent type 1 diabetes in children with a high genetic risk.
- What could go wrong
- This is a large but early-stage prevention trial. It may not prove that the vaccine reduces diabetes risk, and results may take years. The vaccine has known side effects like fever or allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AUF DER BULT, Kinder- und Jugendkrankenhaus
RECRUITINGHanover, Lower Saxony, 30173, Germany
-
Birmingham Women's and Children's NHS Foundation Trust
NOT_YET_RECRUITINGBirmingham, United Kingdom
-
Cambridge University Hospitals NHS Foundation Trust
NOT_YET_RECRUITINGCambridge, United Kingdom
-
Klinik und Poliklinik f. Kinder und Jugendmedizin, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden
RECRUITINGDresden, Saxony, 01307, Germany
-
Klinikum rechts der Isar of Technical University Munich and Institute for Diabetes Research, Helmholtz Munich
RECRUITINGMunich, Bavaria, 80939, Germany
-
Lund University Dep. of Clinical Sciences Malmo, Skane University Hospital SUS
RECRUITINGMalmö, 20213, Sweden
-
Medical University of Vienna, Dept. of Pediatric and Adolescent Medicine, Waehringer Gürtel 18-20, 1090 Vienna, Austria
NOT_YET_RECRUITINGVienna, 1090, Austria
-
The Newcastle upon Tyne Hospitals NHS Foundation Trust
RECRUITINGNewcastle, United Kingdom
-
University Hospitals Leuven, Faculty of Medicine, Catholic University of Leuven
RECRUITINGLeuven, 3000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a stress hormone be behind the hidden danger of low blood sugar?
- Can a peptide tame type 1 diabetes?
- Can a tiny implant track glucose, ketones, and lactate in diabetes?
- Wearable sensor could unmask hidden blood sugar chaos in stomach paralysis
- A smarter insulin that aims for the liver could curb dangerous nighttime dips
- Smart insulin pump may boost brain and body health in older adults with diabetes